Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_18379:p1
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 18379 (pt 1/3)
Character Range: 1041512–1044507

18379                      Botulinum Toxin Type A Purified Neurotoxin Complex (Botox), intravesial injection of, with cystoscopy, for the treatment of urinary incontinence, including all such injections on any one day, if:                                                                                                                                                                                            239.20
                           (a) the urinary incontinence is due to idiopathic overactive bladder in a patient; and
                           (b) the patient is at least 18 years of age; and
                           (c) the patient has urinary incontinence that is inadequately controlled by at least 2 alternative anti‑cholinergic agents, as manifested by having experienced at least 14 episodes of urinary incontinence per week before commencement of treatment with botulinum toxin; and
                           (d) the patient is willing and able to self‑catheterise; and
                           (e) treatment is not provided on the same occasion as a service described in item 104, 105, 110, 116, 119, 11900 or 11919
                           Applicable only once unless the patient achieves at least a 50% reduction in urinary incontinence episodes from baseline at any time during the period of 6 to 12 weeks after first treatment
                           (H) (Anaes.)

Division 5.9—Group T10: Anaesthesia performed in connection with certain services (Relative Value Guide)

5.9.1A  Meaning of base unit
  In an item in Group T10:
base unit means an amount of $22.55.

5.9.1  Meaning of amount under clause 5.9.1
 (1) In item 25025:
amount under clause 5.9.1 means 50% of the sum of:
 (a) the fee mentioned in any of items 20100 to 21997 or 22900 for the initiation of the management of anaesthesia in association with which the anaesthesia is performed; and
 (b) the fee mentioned in the item in the range 23010 to 24136 that applies to the anaesthesia; and
 (c) if any of items 25000 to 25014 applies to the anaesthesia—the fee mentioned in the item; and
 (d) if a service described in any of items 22002 to 22051 is performed in association with the anaesthesia—the fee mentioned in the item.
 (2) In item 25030:
amount under clause 5.9.1 means 50% of the sum of:
 (a) the fee mentioned in the item in the range 25200 to 25205 that applies to the assistance; and
 (b) the fee mentioned in the item in the range 23010 to 24136 that applies to the assistance; and
 (c) if any of items 25000 to 25014 applies to the anaesthesia—the fee mentioned in the item; and
 (d) if a service described in any of items 22002 to 22051 is performed in association with the assistance—the fee mentioned in the item.
 (3) In item 25050:
amount under clause 5.9.1 means 50% of the sum of:
 (a) the fee mentioned in item 22060; and
 (b) the fee mentioned in the item in the range 23010 to 24136 that applies to the perfusion; and
 (c) if any of items 25000 to 25014 apply to the